Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-28 · accession 0001209191-21-071563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-29 | 2021-12-28 | ARWR | GIVEN DOUGLAS B | Dir | G - Gift | $0.00 | -655 | 109.2K | -0.6% | $0 | |
| 2021-12-29 | 2021-12-28 | ARWR | GIVEN DOUGLAS B | Dir | P - Purchase | $66.37 | +655 | 109.9K | +0.6% | +$43.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | G | D | 655 | $0.00 | 109,213 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-28 | P | A | 655 | $66.37 | 109,868 | D | — | — | (F1) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |